Everslide
Special Situations, LLC · Decision date Sep 23, 2026
What did the FDA decide?
FDA's 510(k) database records K260117 for the device Everslide, submitted by Special Situations, LLC of Tulsa, Oklahoma, and classified under product code NUC as a personal lubricant (21 CFR 884.5300) in the Obstetrics/Gynecology specialty. The record lists a traditional 510(k) received on 01/14/2026, not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan.
FDA recorded a decision of Substantially Equivalent (SESE) on 2026-09-23, meaning the submission was cleared for marketing as substantially equivalent to a predicate device; this is a 510(k) clearance, not premarket approval. The available record does not identify the predicate device, the specific materials or components of Everslide, or the contents of the summary; those details would need to be read from the linked FDA summary document.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Obstetrics/Gynecology
- Decision date
- Sep 23, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260117
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Special Situations, LLC
- Product code
- NUC
- Decision code
- SESE
- Decision date
- Sep 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Lubricant, Personal.
- Applicant
- Special Situations, LLC
- Product code
- NUC
- FDA device class
- 2
FDA decision timeline
K260117 received
Application receipt date recorded by FDA.
K260117 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NUC
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Maxigen Biotech, Inc. | 510(k) clearance | Sep 3, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Special Situations, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Tulsa, OK
Sources and methodology
- Original FDA record: K260117
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records